In this episode, Steve is joined by two members of the global health team to discuss their new commentary on the race for a Covid-19 vaccine: Katherine Bliss, GHPC Senior Fellow and Anna Carroll, GHPC Associate Fellow. Nationalism among the wealthier and more powerful countries dominates the global scramble for a vaccine. They have locked up much of the future production of promising vaccines, while low and middle income countries are at risk of being left empty-handed and uncertain, at the back of the queue. One emerging and promising initiative is the COVAX vaccine facility, led by Gavi and the Coalition for Epidemic Preparedness Innovations (CEPI), which seeks to ensure timely access and equity to vaccines, under the broad umbrella of the ACT-Accelerator. What’s the rationale for these efforts, how are they structured and financed, and what is required to sustain them and put them on a path to success? Who are its strongest supporters? And what is the national security case for the United States pursuing a blend of both nationalism and internationalism, in support of COVAX. What specifically are we arguing that the United States should do?